Growth Metrics

Acadia Pharmaceuticals (ACAD) EBT Margin (2010 - 2026)

Acadia Pharmaceuticals' quarterly EBT Margin came in at 1.49% in Q1 2026, down 989.0% year-on-year from 0.17% in Q1 2025, and down 83.89% quarter-over-quarter from 9.26% in Q4 2025.

Acadia Pharmaceuticals has reported EBT Margin for 17 years, with the latest figure at 1.49% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 989.0% year-over-year to 1.49%; the trailing twelve-month figure through Mar 2026 stood at 10.51% (down 1608.0% YoY), and the FY2025 full-year result was 12.96%, down 1398.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 1.49%, down from 9.26% in the prior quarter.
  • The five-year high for EBT Margin was 62.05% in Q4 2024, with the low at 97.49% in Q1 2022.
  • Average EBT Margin over 5 years is 3.39%, with a median of 9.26% recorded in 2025.
  • Year-over-year, EBT Margin jumped 5956 bps in 2023 and slumped 5278 bps in 2025.
  • Tracing ACAD's EBT Margin over 5 years: stood at 29.92% in 2022, then soared by 157 bps to 17.17% in 2023, then soared by 261 bps to 62.05% in 2024, then tumbled by 85 bps to 9.26% in 2025, then tumbled by 84 bps to 1.49% in 2026.
  • The last three EBT Margin figures came in at 1.49% (Q1 2026), 9.26% (Q4 2025), and 16.0% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -6.40%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 41.95%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 23.05%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 18.99%
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn 1.49%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.49%
Dec 31, 2025 9.26%
Sep 30, 2025 16.00%
Jun 30, 2025 15.19%
Mar 31, 2025 11.38%
Dec 31, 2024 62.05%
Sep 30, 2024 15.50%
Jun 30, 2024 15.37%
Mar 31, 2024 10.20%
Dec 31, 2023 17.17%
Sep 30, 2023 -24.61%
Jun 30, 2023 3.84%
Mar 31, 2023 -37.94%
Dec 31, 2022 -29.92%
Sep 30, 2022 -20.20%
Jun 30, 2022 -24.95%
Mar 31, 2022 -97.49%
Dec 31, 2021 -32.81%
Sep 30, 2021 -11.24%
Jun 30, 2021 -37.67%
Mar 31, 2021 -62.34%
Dec 31, 2020 -54.83%
Sep 30, 2020 -70.38%
Jun 30, 2020 -37.92%
Mar 31, 2020 -97.73%
Dec 31, 2019 -53.53%
Sep 30, 2019 -44.66%
Jun 30, 2019 -65.59%
Mar 31, 2019 -134.90%
Dec 31, 2018 -109.92%
Sep 30, 2018 -105.93%
Jun 30, 2018 -110.49%
Mar 31, 2018 -109.78%
Dec 31, 2017 -158.17%
Sep 30, 2017 -181.52%
Jun 30, 2017 -219.99%
Mar 31, 2017 -574.11%
Dec 31, 2016 -646.67%
Sep 30, 2016 -1,359.40%
Jun 30, 2016 -73,527.84%
Mar 31, 2016 -1,244,050.00%
Dec 31, 2015 372,700.00%
Sep 30, 2015 -99,758.97%
Jun 30, 2015 -3,937,800.00%
Mar 31, 2015 -1,009,375.00%
Dec 31, 2014 71,112.77%
Sep 30, 2014 -165,240.00%
Jun 30, 2014 -76,767.86%
Mar 31, 2014 -59,426.67%
Dec 31, 2013 36,070.27%
Sep 30, 2013 -4,456.25%
Jun 30, 2013 -2,013.53%
Mar 31, 2013 -1,468.35%
Dec 31, 2012 -1,792.11%
Sep 30, 2012 -69.06%
Jun 30, 2012 -904.67%
Mar 31, 2012 -1,381.78%
Dec 31, 2011 -901.36%
Sep 30, 2011 -869.18%
Jun 30, 2011 -1,425.22%
Mar 31, 2011 -1,340.92%
Dec 31, 2010 83.98%
Sep 30, 2010 -183.70%